Skip to main content
. 2016 Aug 9;9:4859–4866. doi: 10.2147/OTT.S97861

Figure 5.

Figure 5

NanogP8 promotes SGC7901 cell proliferation through Akt/mTOR pathway.

Notes: (A) Western blot analysis of expression of indicated proteins in pEGFP-N1 and pEGFP-N1-NanogP8-transfected SGC-7901 cells. (B) SGC-7901 cells were transfected with pEGFP-N1-NanogP8 for 24 hours and then treated with mTOR inhibitor rapamycin (50 nM) for another 24 hours. The cell viability was detected by CCK8. Data represent mean ± SD of three independent experiments. *P<0.05 represents cell viability in (GFP- GFP-NanogP8+ Rapamycin-) group compared to the (GFP+ GFP-NanogP8- Rapamycin-) and (GFP-NanogP8+ Rapamycin+) group, respectively.

Abbreviation: SD, standard deviation.